Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Completed
CT.gov ID
NCT04984941
Collaborator
(none)
100
1
19
5.3

Study Details

Study Description

Brief Summary

One hundred patients were enrolled, based on sensitization and doctor-diagnosed allergy to HDM. Questionnaires were administered to document demographic and clinical characteristics. Serum IgE reactivity toDermatophagoides pteronyssinus (Dp) extract, Der p 1, Der p 2 and Der p 10 was measured by ImmunoCAP.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Background: The role of specific IgE (sIgE) against Der p 1and Der p 2 in Chinese patients with house dust mite (HDM)allergy has not yet been well investigated.Methods: One hundred patients were enrolled, based on sensitization and doctor-diagnosed allergy to HDM. Questionnaires were administered to document demographic and clinical characteristics. Serum IgE reactivity toDermatophagoides pteronyssinus (Dp) extract, Der p 1, Der p 2 and Der p 10 was measured by ImmunoCAP.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    100 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients
    Actual Study Start Date :
    Mar 1, 2013
    Actual Primary Completion Date :
    Mar 1, 2014
    Actual Study Completion Date :
    Oct 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. Demographic Characteristics [1 year]

      Describe the patient's basic information in detail, including age, gender, family history, etc

    2. Der p 1 Serum IgE [1 year]

      Prevalence of Der p 1 Serum IgE in HDM-Allergic Patients

    3. Der p 2 Serum IgE [1 year]

      Prevalence of Der p 2 Serum IgE in HDM-Allergic Patients

    4. Dp, Der p 1 and Der p 2 [1 year]

      Relationship between Serum IgE Levels of Dp, Der p 1 and Der p 2

    5. Factors associated with specific IgE against Der p 1 [1 year]

      Study the patient's basic information and identify factors that are clearly associated with specific IgE against Der p 1

    6. Factors associated with specific IgE against Der p 2 [1 year]

      Study the patient's basic information and identify factors that are clearly associated with specific IgE against Der p 2

    7. the Number of Affected Organs [1 year]

      Association of Specific IgE Titers with the Number of Affected Organs

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • HDM-allergic patients reporting allergic rhinitis, conjunctivitis, asthma and/or atopic dermatitis and who had never undergone immunotherapy, were enrolled if they were sensitized to Dp as judged by ImmunoCAP ( ≥ 1 kU/l) and/or skin reaction index (SRI)by skin-prick test (SPT, a wheal diameter ≥ 0.5 mm).
    Exclusion Criteria:
    • Patients who refused to participate in the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Second Affiliated Hospital,School of Medicine,Zhejiang University Hangzhou Zhejiang China

    Sponsors and Collaborators

    • Second Affiliated Hospital, School of Medicine, Zhejiang University

    Investigators

    • Study Chair: Wang Huiying, 2nd affiliated Hospital,School of Medicine,Zhejiang University,China

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Second Affiliated Hospital, School of Medicine, Zhejiang University
    ClinicalTrials.gov Identifier:
    NCT04984941
    Other Study ID Numbers:
    • 2012-047
    First Posted:
    Aug 2, 2021
    Last Update Posted:
    Aug 2, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Second Affiliated Hospital, School of Medicine, Zhejiang University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 2, 2021